Physician profile
Deepa Raghunathan
NPI 1124462650
$2,725.96
in general payments reported to CMS, 2019-2025
14 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $245 · 2021: $172 · 2022: $323 · 2023: $381 · 2024: $936 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $774 · Travel and Lodging: $504 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $774.12 |
| Travel and Lodging | $503.68 |
| Education | $197.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,204.96 | 2019-2025 | Cardiomems, Amplatzer Amulet, Mitraclip |
| Boston Scientific Corporation | $379.70 | 2019 | |
| Biosense Webster, INC. | $307.51 | 2021-2025 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $176.30 | 2020-2023 | Andexxa |
| Edwards Lifesciences Corporation | $106.72 | 2021-2025 | |
| Astellas Pharma US INC | $99.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $88.70 | 2020-2024 | Xarelto |
| Amgen INC. | $81.60 | 2023-2024 | Repatha |
| Bridgebio Pharma, INC. | $66.94 | 2025 | Attruby |
| Medtronic Vascular, INC. | $63.37 | 2019 | |
| Lantheus Medical Imaging, INC. | $62.76 | 2019-2025 | Definity |
| Pfizer INC. | $55.48 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $19.81 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $13.11 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepa Raghunathan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.